Sort
50,496 grants matching “lung cancer”
Detection of metastases in lymph nodes using quantitative ultrasound
$706,909Ernest Joseph Feleppa · Riverside Research Institute · R01 · FY2016 · CA
NORTH CENTRAL CANCER TREATMENT GROUP
$706,898Mayo Clinic Coll Of Medicine, Rochester · U10 · FY2003 · CA
SMART Cancer Care Teams: Enhancing EHR Communication to Improve Interprofessional Teamwork
$706,838Shin-Ping Tu · University Of California At Davis · R01 · FY2022 · CA
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
$706,749Steven M Larson · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
$706,743Virginia Chih-Yi Sun · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
$706,743Virginia Chih-Yi Sun · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Broad Genomic Profiling in patients with advanced lung cancer: empirically assessing adoption, clinical utility, and the value of additional evidence in an evolving landscape of cancer care
$706,720Cary P Gross · Yale University · R01 · FY2023 · CA
The MB-CCOP at Boston Medical Center
$706,684Lisa A. Kachnic · Boston Medical Center · U10 · FY2010 · CA
Immunotherapy to deplete key Treg subsets in solid tumors
$706,495Peter David Suzdak · Sonoval Llc · R44 · FY2025 · CA
PLCO EEMS and Extended Follow Up
$706,495Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Stroger Hospital of Cook County, Department of Surgery,*
$706,480Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2008 · CA
Stationary Digital Tomosynthesis for Transbronchial Biopsy Guidance
$706,479Yueh Z Lee · Univ Of North Carolina Chapel Hill · R01 · FY2022 · EB
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
$706,425Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2022 · CA
Lung cancer oncogenotype-selective drug target discovery
$706,409Michael G Roth · Ut Southwestern Medical Center · U01 · FY2016 · CA
Lung cancer oncogenotype-selective drug target discovery
$706,409Michael G Roth · Ut Southwestern Medical Center · U01 · FY2015 · CA
Ultrasound-guided DNA delivery for regenerative medicine
$706,386Dan Gazit · Cedars-Sinai Medical Center · R01 · FY2020 · EB
Ultrasound-guided DNA delivery for regenerative medicine
$706,386Dan Gazit · Cedars-Sinai Medical Center · R01 · FY2019 · EB
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
$706,386Elizabeth Chiao · Baylor College Of Medicine · R01 · FY2018 · CA
IMAGING AND EXOSOMAL GENOMICS AS AN EARLY IDENTIFIER OF LUNG CANCER
$706,223The Leland Stanford Junior University · · FY2020 · Defense Health Agency
Understanding and addressing rejection of personalized cancer risk information
$706,184Laura D. Scherer · University Of Colorado Denver · R01 · FY2024 · CA
DCTD Preclinical In Vivo/In Vitro Assay Development
$706,171David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
$706,103Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AR
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
$706,097Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2023 · CA
A transformative drug discovery platform for allosteric kinase inhibitors
$706,093Nicholas Mark Levinson · University Of Minnesota · R01 · FY2025 · CA
Vascular, Pulmonary and Renal Injury
$706,035Michael A Gimbrone · Brigham And Women'S Hospital · T32 · FY2010 · HL